TELPEV Trademark

Trademark Overview

On Monday, November 8, 2010, a trademark application was filed for TELPEV with the United States Patent and Trademark Office. The USPTO has given the TELPEV trademark a serial number of 85171278. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 16, 2014. This trademark is owned by Vertex Pharmaceuticals Incorporated. The TELPEV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of viral diseases, bacterial infections, cystic fibrosis, cancer, autoimmune diseases, inflammatory diseases, neurological disorders and epilepsy
telpev

General Information

Serial Number85171278
Word MarkTELPEV
Filing DateMonday, November 8, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 16, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of viral diseases, bacterial infections, cystic fibrosis, cancer, autoimmune diseases, inflammatory diseases, neurological disorders and epilepsy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 12, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, June 16, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 16, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 14, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 14, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 15, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 14, 2013EXTENSION 5 GRANTED
Thursday, November 7, 2013EXTENSION 5 FILED
Thursday, November 7, 2013TEAS EXTENSION RECEIVED
Tuesday, April 30, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 27, 2013EXTENSION 4 GRANTED
Thursday, April 25, 2013EXTENSION 4 FILED
Thursday, April 25, 2013TEAS EXTENSION RECEIVED
Friday, October 26, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 25, 2012EXTENSION 3 GRANTED
Tuesday, October 23, 2012EXTENSION 3 FILED
Tuesday, October 23, 2012TEAS EXTENSION RECEIVED
Thursday, May 17, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 16, 2012EXTENSION 2 GRANTED
Tuesday, April 24, 2012EXTENSION 2 FILED
Wednesday, May 16, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 24, 2012TEAS EXTENSION RECEIVED
Thursday, November 10, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 8, 2011EXTENSION 1 GRANTED
Tuesday, November 8, 2011EXTENSION 1 FILED
Tuesday, November 8, 2011TEAS EXTENSION RECEIVED
Tuesday, May 10, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 15, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 15, 2011PUBLISHED FOR OPPOSITION
Saturday, February 5, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, January 31, 2011ASSIGNED TO LIE
Wednesday, January 26, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 26, 2011ASSIGNED TO EXAMINER
Friday, November 12, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 11, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

telpev diseases inflammatory cancer autoimmune neurological epilepsy disorders fibrosis cystic treatment